Hepatitis C: An update

Australian Family Physician

Volumn 42, Issue 7, 2013, Pages 452-456

  Holmes, Jacinta ^a   Thompson, Alexander ^a   Bell, Sally ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Chronic disease therapy; Communicable infectious diseases; Gastrointestinal diseases; Hepatitis C; Substance related disorder

Indexed keywords

EID: 84880724233     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report 2012. Sydney NSW: The Kirby Institute, the University of New South Wales, 2012.
2. Gidding HF, Topp L, Middleton M, et al. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997- 2006. J Gastroenterol Hepatol 2009;24:1648-54.
3. Day CA, White B, Thein HH, et al. Experience of hepatitis C testing among injecting drug users in Sydney, Australia. AIDS Care 2008;20:116-23.
4. Gidding HF, Law MG, Amin J, et al. Predictors of deferral of treatment for hepatitis C infection in Australian clinics. Med J Aust 2011;194:398-402.
5. Grebely J, Bryant J, Hull P, et al. Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia. J Viral Hepat 2011;18:e104-16.
6. Treloar C, Hull P, Dore GJ, Grebely J. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Drug Alcohol Rev 2012;31:918-24.
7. Centers for Disease Control and Prevention. Hepatitis C information for health professionals: statistics and surveillance. Available at www.cdc.gov/ hepatitis/HCV/StatisticsHCV.htm [Accessed 10 February 2013].
8. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009;461:798-801.
9. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36(5 Suppl 1):S35-46.
10. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006;368:938-45.
11. Di Bisceglie AM, Stoddard AM, Dienstag JL, et al. Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon. Hepatology 2011;53:1100-8.
12. Afdhal NH. The natural history of hepatitis C. Semin Liver Dis 2004;24(Suppl 2):3-8.
13. Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterol 1997;112:463-72.
14. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003;22:5093-107.
15. Hiotis SP, Rahbari NN, Villanueva GA, et al. Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma. BMC Gastroenterol 2012;12:64.
16. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
17. Gellert L, Jalaludin B, Levy M. Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most. Inter Med J 2007;37:516-22.
18. Hepatitis C Virus Projections Working Group. Estimates and projections of the hepatitis C virus epidemic in Australia 2006. Canberra: Hepatitis C Sub-Committee, Ministerial Advisory Committee on AIDS Sexual Health and Hepatitis, 2006.
19. Thein HH, Walter SR, Gidding HF, et al. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007. J Viral Hepat 2011;18:e232-41.
20. Law MG, Dore GJ, Bath N, et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 2003;32:717-24.
21. Mayer KE, Myers RP, Lee SS. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat 2005;12:559-67.
22. Gordon A, Hobbs DA, Bowden DS, et al. Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C. J Gastroenterol Hepatol 2006;21(1 Pt 2):275-80.